🎗️Лента новостей
Онкология
Collaboration and Research Investment Drive Progress in Cancer Prevention and Screening - NCI
Collaboration and Research Investment Drive Progress in Cancer Prevention and Screening - NCI Oncodaily
Онкология
BioNTech mRNA cancer immunotherapy misses first objective in key study
BioNTech mRNA cancer immunotherapy misses first objective in key study BioPharma Dive
Онкология
BioNTech mRNA cancer immunotherapy misses first objective in key study
BioNTech mRNA cancer immunotherapy misses first objective in key study Yahoo Finance
Онкология
American Society for Radiation Oncology, Sept. 26-30
American Society for Radiation Oncology, Sept. 26-30 HealthDay
Онкология
BioNTech’s Cancer Drug Misses A Key Trial Goal – Citi Says Survival Data Could Preserve ‘A Meaningful Development Path’
BioNTech’s Cancer Drug Misses A Key Trial Goal – Citi Says Survival Data Could Preserve ‘A Meaningful Development Path’ TradingView
🎗️
Онкология
На Сахалине впервые в ДФО начали применять радиоэмболизацию при лечении рака
На Сахалине впервые в ДФО начали применять радиоэмболизацию при лечении рака Наука Mail
Онкология
Trial Offers Metastatic Breast Cancer Treatment Without Chemotherapy or Radiation | Newswise
Trial Offers Metastatic Breast Cancer Treatment Without Chemotherapy or Radiation | Newswise Newswise
Онкология
Ученые выяснили, почему рак поджелудочной железы так трудно победить
Ученые выяснили, почему рак поджелудочной железы так трудно победить Наука Mail
Онкология
Targeted radioactive therapy may help delay spread of recurrent prostate cancer
Adding the targeted radioactive drug 177Lu-PNT2002 to stereotactic body radiation therapy, or SBRT, may help keep recurrent prostate cancer under control longer than SBRT alone, according to new research led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center.
Онкология
Tumor suppressor gene mutations trigger immune activation in early oral cancer
Head and neck squamous cell carcinoma (HNSCC) frequently develops in the oral and upper aerodigestive regions following chronic exposure to mutagenic factors such as tobacco, alcohol and betel nut. Alterations in the tumor suppressor genes TP53 and CDKN2A are among the most common genetic changes in HNSCC and often…
Онкология
Онколог развеял миф о том, что смартфоны вызывают рак
Онколог развеял миф о том, что смартфоны вызывают рак Национальная Служба Новостей
Онкология
Cancer Patients in Rural South Africa Carry a Heavy Burden of Fear, Pain and Poverty
Cancer Patients in Rural South Africa Carry a Heavy Burden of Fear, Pain and Poverty Bioengineer.org
Онкология
BioNTech misses PFS endpoints in Phase II/III cancer vaccine trial
BioNTech misses PFS endpoints in Phase II/III cancer vaccine trial Clinical Trials Arena